CELLEX
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

CELLEX Trademark

Serial Number: 79211796 • Registration: 5494508

CELLEX is a trademark filed by Cellex Gesellschaft für Zellgewinnung mbH on August 19, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 39 (Transportation & Storage), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Cellex Gesellschaft für Zellgewinnung mbH (3 trademarks)

Fiedlerstraße 36

Entity Type: 99

Cellex Cell Professionals GmbH (3 trademarks)

Im Mediapark 6b
Cologne 50670 , DE

Entity Type: 99

Trademark Details

Filing Date

August 19, 2016

Registration Date

June 19, 2018

Published for Opposition

April 3, 2018

Goods & Services

Consumer survey services which determine blood donor and stem cell donor suitability; statistical collection of donor data; Telemarketing donors; The bringing together of consumers and providers of a variety of goods and services in the field of blood donation and stem cell donation for commercial purposes via the internet

Courier services, escorted courier services for the transport of stem cell, bone marrow and cell products, blood and pharmaceuticals; unescorted transport of stem cell, bone marrow and cell products, blood and pharmaceuticals; delivery of blood samples; cryogenic transport of cryogenically preserved blood, stem cell and cell products

Medical testing for suitability of stem cell donors, for others; providing medical information for patients and stem cell donors, for others; medical preparation of stem cell donors [ by altering the donor's metabolism by injection of a second messenger substance that causes excess creation and mobilization of stem cells into the donor's blood days prior to donation ] , being a service for others; Medical services in the nature of providing continuous medical care and medical preparation of receptors to be ready for stem cell reception and medical care and coordination of stem cell donation, all being a time critical medical service for others

Monoclonal antibodies for medical treatment and for diagnostics to bind or mask biological molecules in blood, serum plasma or tissue; blood for medical purposes; blood plasma

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
Apr 23, 2026 INNP
GENERIC MADRID TRANSACTION SENT TO IB
Feb 24, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 24, 2026 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 10, 2025 INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 7, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jul 3, 2025 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jul 3, 2025 C75A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jun 30, 2025 EROP
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Jan 7, 2025 PR75
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 6, 2025 APRE
TEAS SECTION 71 & 15 RECEIVED
Jun 18, 2024 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 19, 2023 REM3
TTAB RELEASE CASE TO TRADEMARKS
Dec 29, 2022 TMBN
CANCELLATION TERMINATED NO. 999999
Dec 29, 2022 CANT
CANCELLATION DENIED NO. 999999
Dec 29, 2022 CAND
CANCELLATION INSTITUTED NO. 999999
Jan 31, 2022 PETC
NEW REPRESENTATIVE AT IB RECEIVED
Nov 6, 2020 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 23, 2020 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 12, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 22, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 22, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 19, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 19, 2018 R.PR
PUBLISHED FOR OPPOSITION
Apr 3, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Mar 30, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 14, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 14, 2018 OP2R
NOTICE OF PUBLICATION
Mar 14, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 23, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 7, 2018 ERFR
FINAL REFUSAL MAILED
Jan 29, 2018 CNFR
FINAL REFUSAL WRITTEN
Jan 26, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2018 CRFA
ASSIGNED TO LIE
Jan 18, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 2, 2018 TROA
REFUSAL PROCESSED BY IB
Aug 4, 2017 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 19, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jul 19, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Jul 15, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 13, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jul 12, 2017 CNRT
ASSIGNED TO EXAMINER
Jul 11, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 6, 2017 REPR